All In MedTech

Device Trial Radar · NCT02997553

Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery

Reliability of Indocyanine Green Use in Sentinel Lymph Node Identification in Cancer Surgery

Last checked: Nov 19, 2026Latest source record: Sep 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

744

Actual

Start

Nov 29, 2017

Primary completion

Sep 19, 2022

Study completion Oct 12, 2022

Sponsor

Lead sponsor
Institut de Cancérologie de LorraineAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Dec 20, 2016

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a single-center prospective clinical trial to evaluate non-inferiority of indocyanine green guided sentinel lymph node biopsy compared with the gold standard Technecium99 guided sentinel lymph node biopsy in patients with cancers and subjected to surgery. The diagnostic performance and the tolerance of indocyanine green (ICG) to the radio-isotope (Techniciun99) in the detection of sentinel lymph nodes will be assess using an "Optonuclear" probe (EURORAD S.A.) and QUEST camera

Conditions

  • Breast Carcinoma
  • Head and Neck Cancer
  • Melanoma (Skin)
  • Squamous Cell Carcinoma, Skin
  • Cervix Cancer
  • Endometrium Cancer
  • Ovary Cancer
  • Vulva Cancer
  • Anus Cancer
  • Rectum Cancer

Interventions

  • Indocyanine greenDrug

    Each patient receive injection of indocyanine green just before surgery Specify total dose : 2.5 mg/ml (Intravenous use)

  • Technetium99Drug

    Each patient receives injection of Technetium 99 ( injected in subcutaneously) before surgery. Lymphoscintigraphy is performed to identify the sentinel node

  • Optonuclear probeDevice

    The detection of sentinel lymph node will be conducted by an optonuclear probe able to detect the radioactive and the fluorescence signal during surgery.

  • Quest CameraDevice

    The detection of sentinel lymph node will be conducted by a camera able to determine imagery of fluorescence during surgery.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Non-inferiority of indocyanine green guided sentinel lymph node biopsyTime frame: 1 day

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Institut de Cancérologie de Lorraine

    Vandœuvre-lès-Nancy, France

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.